Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1986 Apr;45(4):339–344. doi: 10.1136/ard.45.4.339

Effects of cyclosporin on collagen induced arthritis in mice.

K Takagishi, N Kaibara, T Hotokebuchi, C Arita, M Morinaga, K Arai
PMCID: PMC1001880  PMID: 3754714

Abstract

We have studied the effect of the immunosuppressive agent cyclosporin on collagen induced arthritis in mice. Cyclosporin, when given prophylactically, was capable of suppressing the development of collagen induced arthritis and the immunological response to native type II collagen in a dose dependent manner. Furthermore, treatment with cyclosporin, started on the same day as the booster injection with type II collagen, also resulted in inhibition of development of arthritis and of immunity to collagen. These findings suggest that the time of a booster injection, three weeks after the initial immunisation, might be still within the induction phase of arthritis since reinoculation is required to produce a high incidence of arthritis in mice. In addition, therapeutic treatment with cyclosporin did not affect the clinical course of the disease or the immune response to collagen.

Full text

PDF
339

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Borel J. F., Feurer C., Gubler H. U., Stähelin H. Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions. 1976 Jul;6(4):468–475. doi: 10.1007/BF01973261. [DOI] [PubMed] [Google Scholar]
  2. Brahn E., Trentham D. E. Effect of antithymocyte serum on collagen arthritis in rats: evidence that T cells are involved in its pathogenesis. Cell Immunol. 1984 Jul;86(2):421–428. doi: 10.1016/0008-8749(84)90397-6. [DOI] [PubMed] [Google Scholar]
  3. Bunjes D., Hardt C., Röllinghoff M., Wagner H. Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2. Eur J Immunol. 1981 Aug;11(8):657–661. doi: 10.1002/eji.1830110812. [DOI] [PubMed] [Google Scholar]
  4. Caulfield J. P., Hein A., Dynesius-Trentham R., Trentham D. E. Morphologic demonstration of two stages in the development of type II collagen-induced arthritis. Lab Invest. 1982 Mar;46(3):321–343. [PubMed] [Google Scholar]
  5. Courtenay J. S., Dallman M. J., Dayan A. D., Martin A., Mosedale B. Immunisation against heterologous type II collagen induces arthritis in mice. Nature. 1980 Feb 14;283(5748):666–668. doi: 10.1038/283666a0. [DOI] [PubMed] [Google Scholar]
  6. Henderson B., Staines N. A., Burrai I., Cox J. H. The anti-arthritic and immunosuppressive effects of cyclosporine on arthritis induced in the rat by type II collagen. Clin Exp Immunol. 1984 Jul;57(1):51–56. [PMC free article] [PubMed] [Google Scholar]
  7. Hess A. D., Tutschka P. J., Santos G. W. Effect of cyclosporin A on human lymphocyte responses in vitro. II. Induction of specific alloantigen unresponsiveness mediated by a nylon wool adherent suppressor cell. J Immunol. 1981 Mar;126(3):961–968. [PubMed] [Google Scholar]
  8. Hinrichs D. J., Wegmann K. W., Peters B. A. The influence of cyclosporin A on the development of actively induced and passively transferred experimental allergic encephalomyelitis. Cell Immunol. 1983 Apr 1;77(1):202–209. doi: 10.1016/0008-8749(83)90020-5. [DOI] [PubMed] [Google Scholar]
  9. Homan W. P., Fabre J. W., Williams K. A., Millard P. R., Morris P. J. Studies on the immunosuppressive properties of cyclosporin a in rats receiving renal allografts. Transplantation. 1980 May;29(5):361–366. doi: 10.1097/00007890-198005000-00003. [DOI] [PubMed] [Google Scholar]
  10. Kaibara N., Hotokebuchi T., Takagishi K., Katsuki I., Morinaga M., Arita C., Jingushi S. Pathogenetic difference between collagen arthritis and adjuvant arthritis. J Exp Med. 1984 May 1;159(5):1388–1396. doi: 10.1084/jem.159.5.1388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kaibara N., Hotokebuchi T., Takagishi K., Katsuki I. Paradoxical effects of cyclosporin A on collagen arthritis in rats. J Exp Med. 1983 Dec 1;158(6):2007–2015. doi: 10.1084/jem.158.6.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kaibara N., Morinaga M., Arita C., Hotokebuchi T., Takagishi K. Serum transfer of collagen arthritis to cyclosporin-treated, type II collagen-tolerant rats. Clin Immunol Immunopathol. 1985 May;35(2):252–260. doi: 10.1016/0090-1229(85)90071-6. [DOI] [PubMed] [Google Scholar]
  13. King R. H., Craggs R. I., Gross M. L., Tompkins C., Thomas P. K. Suppression of experimental allergic neuritis by Cyclosporin-A. Acta Neuropathol. 1983;59(4):262–268. doi: 10.1007/BF00691491. [DOI] [PubMed] [Google Scholar]
  14. Klareskog L., Holmdahl R., Larsson E., Wigzell H. Role of T lymphocytes in collagen II induced arthritis in rats. Clin Exp Immunol. 1983 Jan;51(1):117–125. [PMC free article] [PubMed] [Google Scholar]
  15. Larsson E. L. Cyclosporin A and dexamethasone suppress T cell responses by selectively acting at distinct sites of the triggering process. J Immunol. 1980 Jun;124(6):2828–2833. [PubMed] [Google Scholar]
  16. Morris P. J. Cyclosporin A. Transplantation. 1981 Nov;32(5):349–354. [PubMed] [Google Scholar]
  17. Nussenblatt R. B., Rodrigues M. M., Salinas-Carmona M. C., Gery I., Cevario S., Wacker W. Modulation of experimental autoimmune uveitis with cyclosporin A. Arch Ophthalmol. 1982 Jul;100(7):1146–1149. doi: 10.1001/archopht.1982.01030040124022. [DOI] [PubMed] [Google Scholar]
  18. Palacios R., Möller G. Cyclosporin A blocks receptors for HLA-DR antigens on T cells. Nature. 1981 Apr 30;290(5809):792–794. doi: 10.1038/290792a0. [DOI] [PubMed] [Google Scholar]
  19. Phadke K., Carroll J., Nanda S. Effects of various anti-inflammatory drugs on type II collagen-induced arthritis in rats. Clin Exp Immunol. 1982 Mar;47(3):579–586. [PMC free article] [PubMed] [Google Scholar]
  20. Rogers M. P., Trentham D. E., McCune W. J., Ginsberg B. I., Rennke H. G., Reich P., David J. R. Effect of psychological stress on the induction of arthritis in rats. Arthritis Rheum. 1980 Dec;23(12):1337–1342. doi: 10.1002/art.1780231202. [DOI] [PubMed] [Google Scholar]
  21. Sloboda A. E., Birnbaum J. E., Oronsky A. L., Kerwar S. S. Studies on type II collagen-induced polyarthritis in rats. Effect of antiinflammatory and antirheumatic agents. Arthritis Rheum. 1981 Apr;24(4):616–624. doi: 10.1002/art.1780240408. [DOI] [PubMed] [Google Scholar]
  22. Stuart J. M., Cremer M. A., Kang A. H., Townes A. S. Collagen-induced arthritis in rats. Evaluation of early immunologic events. Arthritis Rheum. 1979 Dec;22(12):1344–1351. doi: 10.1002/art.1780221205. [DOI] [PubMed] [Google Scholar]
  23. Stuart J. M., Cremer M. A., Townes A. S., Kang A. H. Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis. J Exp Med. 1982 Jan 1;155(1):1–16. doi: 10.1084/jem.155.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Stuart J. M., Dixon F. J. Serum transfer of collagen-induced arthritis in mice. J Exp Med. 1983 Aug 1;158(2):378–392. doi: 10.1084/jem.158.2.378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Stuart J. M., Myers L. K., Townes A. S., Kang A. H. Effect of cyclophosphamide, hydrocortisone and levamisole on collagen-induced arthritis in rats. Arthritis Rheum. 1981 Jun;24(6):790–794. doi: 10.1002/art.1780240606. [DOI] [PubMed] [Google Scholar]
  26. Stuart J. M., Townes A. S., Kang A. H. Nature and specificity of the immune response to collagen in type II collagen-induced arthritis in mice. J Clin Invest. 1982 Mar;69(3):673–683. doi: 10.1172/JCI110495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Svenson K. L., Holmdahl R., Klareskog L., Wibell L., Sjöberg O., Klintmalm G. B., Boström H. Cyclosporin A treatment in a case of relapsing polychondritis. Scand J Rheumatol. 1984;13(4):329–333. doi: 10.3109/03009748409111304. [DOI] [PubMed] [Google Scholar]
  28. Takagishi K., Kaibara N., Hotokebuchi T., Arita C., Morinaga M., Arai K. Serum transfer of collagen arthritis in congenitally athymic nude rats. J Immunol. 1985 Jun;134(6):3864–3867. [PubMed] [Google Scholar]
  29. Trentham D. E. Collagen arthritis as a relevant model for rheumatoid arthritis. Arthritis Rheum. 1982 Aug;25(8):911–916. doi: 10.1002/art.1780250801. [DOI] [PubMed] [Google Scholar]
  30. Trentham D. E., Townes A. S., Kang A. H., David J. R. Humoral and cellular sensitivity to collagen in type II collagen-induced arthritis in rats. J Clin Invest. 1978 Jan;61(1):89–96. doi: 10.1172/JCI108929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Vadas M. A., Miller J. F., Gamble J., Whitelaw A. A radioisotopic method to measure delayed type hypersensitivity in the mouse. I. Studies in sensitized and normal mice. Int Arch Allergy Appl Immunol. 1975;49(5):670–692. doi: 10.1159/000231449. [DOI] [PubMed] [Google Scholar]
  32. Voller A., Bidwell D. E., Bartlett A. Enzyme immunoassays in diagnostic medicine. Theory and practice. Bull World Health Organ. 1976;53(1):55–65. [PMC free article] [PubMed] [Google Scholar]
  33. Wood F. D., Pearson C. M., Tanaka A. Capacity of mycobacterial wax D and its subfractions to induce adjuvant arthritis in rats. Int Arch Allergy Appl Immunol. 1969;35(5):456–467. doi: 10.1159/000230198. [DOI] [PubMed] [Google Scholar]
  34. Wooley P. H., Luthra H. S., Stuart J. M., David C. S. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med. 1981 Sep 1;154(3):688–700. doi: 10.1084/jem.154.3.688. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES